(6-Bromoimidazo[1,2-a]pyridin-2-yl)acetic acid, 97.0%, 10g

(2S,3R,4S,5S,6R)-2-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol, 95%, 10mg

N,N'-Bis(2-aminoethyl)-1,3-propanediamine>97.0%(GC)5g

3-(4-((tert-Butoxycarbonyl)amino)phenyl)propanoic acid, 95.0%, 250mg

(5R,6S,7R)-5-(hydroxymethyl)-2-(methylamino)-3a,6,7,7a-tetrahydro-5H-pyrano[3,2-d]thiazole-6,7-diol, 97%, 250mg

3-(4-ethoxyphenyl)-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 2g

1-Bromomethyl-7,7-dimethyl-bicyclo[2.2.1]heptan-2-one, 95.0%, 250mg

(E)-3-(5-Fluoropyridin-2-yl)-2-propenoic acid hydrochloride, 95%, 1g

4-OXOPYRROLIDINE-2-CARBOXYLIC ACID HCL, 95.0%, 1g

1-Cyclobutylpyrimidine-2,4(1H,3H)-dione, 98%, 250mg

2-Hydroxy-4-nitrobenzonitrile, 95.0%, 25g

[4-(2,5-Dioxoimidazolidin-4-yl)phenyl]boronic acid, 95.0%, 250mg

METHYL (R)-1-BOC-3-FLUOROPYRROLIDINE-3-CARBOXYLATE, 95.0%, 5g